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The region of cytoplasm underlying the tight junction (TJ) contains several multimolecular protein complexes, which are involved in
scaffolding of membrane proteins, regulation of cytoskeletal organization, establishment of polarity, and signalling to and from the nucleus. In this
review, we summarize some of the most recent advances in understanding the identity of these proteins, their domain organization, their protein
interactions, and their functions in vertebrate organisms. Analysis of knockdown and knockout model systems shows that several TJ proteins are
essential for the formation of epithelial tissues and early embryonic development, whereas others appear to have redundant functions.
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TJs are of fundamental importance in the physiology of
epithelial cells and tissues. First, they constitute a semi-
permeable barrier that regulates the flow of ions, solutes and
cells across paracellular spaces. Second, they contribute to the
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they are targets and effectors of signalling pathways that control
gene expression, cell differentiation and proliferation. In all
these functions, a key role is played by proteins present in the
cytoplasm underlying the TJ membrane (the TJ bplaque”).
The structural backbone of the TJ plaque is formed by
proteins that contain PDZ domains. The PDZ domain is an
evolutionarily conserved 80–90 residue domain, which was
originally identified in Psd-95 (post-synaptic density protein
95), Dlg (Discs-large, a protein in Drosophila, mutation of
which leads to overgrowth of wing imaginal discs) and ZO-1
(the TJ protein Zonula Occludens 1). PDZ-domain-containing
proteins interact with other PDZ proteins through their PDZ
domains, anchor TJ membrane proteins to the cytoskeleton, and
are implicated in a variety of signalling mechanisms. The sec-
ond, heterogeneous group of TJ proteins is formed by TJ pro-Fig. 1. Schematic representation of cytoplasmic TJ proteins with PDZ domains (P
domains are outlined as colored shapes, or as coiled lines (coiled-coil domains). Num
homology region 3 domain; GUK, guanylate kinase domain; A, acidic domain; WW
domain (first identified in an unconventional myosin family in the mouse mutant “di
binding motif (scaffold module that mediates the formation of heterodimers or h
homology domain (scaffold module found in several proteins involved in the assembly
Please note that polarity complex proteins (PAR-3, PAR-6, PALS-1, PATJ) are discuteins that lack PDZ domains. These proteins appear to be
primarily involved in the regulation of signalling at TJ, rather
than provide the basic structural elements of TJ. The current
review will focus on some of the most recent advances in the
characterization of proteins belonging to these groups, with the
exception of polarity complex proteins of TJ (including aPKC,
PAR-3, PAR-6, PATJ and PALS-1), that are discussed in the
article by Assemat et al., in this issue. The reader is also referred
to other articles in this issue, and to past reviews [1–5] for
additional information on cytoplasmic TJ proteins that are not
mentioned here.
Interestingly, a proteomic approach to analyze the protein
composition of TJ has revealed that the TJ plaque may contain
over 912 protein components, which are found associated with
aPKC in immunoprecipitates. Clusters of proteins related to the
synapse, signalling, cytoskeleton, cell adhesion, and vesicularDZ TJ proteins). The major interacting protein partners are indicated. Protein
bers on the right indicate amino acid number (in the human protein). SH3, Src
, domains with conserved tryptophans; RBD, Rap1 binding domain; DIL, dilute
lute” strain); PR, proline-rich domain; actinBD, actin-binding domain; PB1, PC-
omo-oligomers); CRIB, Cdc42/Rac interactive binding region; L27, LIN-2,-7
of polarized cell-signalling structures); 4.1B, homology domain to protein 4.1B.
ssed in the chapter by Le Bivic et al., in this issue.
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tion, translation and transcription were identified [6]. Although
some of these proteins may associate with aPKC independently
of TJ, these results indicate that our understanding of the
molecular complexity of TJ may still be in its infancy.
2. PDZ proteins of the TJ plaque
A large group of cytoplasmic TJ proteins contains one or
multiple PDZ domains: 1) The ZO proteins (ZO-1, ZO-2, ZO-3);
2) The membrane-associated guanylate kinase inverted proteins
(MAGIs): MAGI-1 and MAGI-3; 3) The multi-PDZ protein
MUPP1; 4) The Ras target protein AF-6/afadin; 5) PAR-3, PAR-
6, PALS-1, and PATJ, which form multiprotein complexes
involved in the establishment of apico-basal epithelial polarity
(see Assemat et al., in this issue) (Fig. 1). PDZ domains have two
major functions: A) to anchor integral membrane proteins
(receptors, adhesion proteins, etc), through the interaction with
their cytoplasmic tails, which contain a specific COOH-terminal
sequence; B) to bind to the PDZ domains of other PDZ proteins,
thus leading to the formation of dimers and scaffolding networks
[7]. Multiple functions of PDZ domains are possible because
subtle changes in PDZ domain structure can have a profound
impact on ligand specificities and biological functions, and the
intrinsic selectivity of PDZ domains is tuned to minimize cross-
reactivity [8,9]. PDZ-containing proteins of TJ contain addi-
tional structural domains, which function as scaffolds for sig-
nalling proteins, such as small GTPases and their regulators,
kinases and transcription factors.
2.1. ZO proteins
ZO-1 (220 kDa) was the first TJ-associated protein to be
identified, through the production of a specific monoclonal
antibody raised against a preparation of liver membranes [10].
Subsequently ZO-2 (160 kDa) and ZO-3 (130 kDa) were
identified as proteins that co-immunoprecipitated with ZO-1
[11,12]. ZO-1, ZO-2 and ZO-3 share a similar structural
organization, with a N-terminal region containing 3 PDZ do-
mains, followed by one SH3 (Src homology 3) domain, and aTable 1
Phenotypes of KO mice/cells for cytoplasmic TJ proteins
Protein Model Phenotype
PTEN Mouse and ES cells Embryonic lethality for mice
tumor development in epithe
AF-6/l-afadin Mouse Embryonic lethality at 10 da
reduction in length of apical
Angiomotin Mouse Embryonic lethality followin
Cingulin ES cells Up-regulation of expression
claudin-7, and occludin. Nor
ZO-1 Mammary epithelial cells (EpH4) TJ structurally and functiona
recruited to junctions. Up-reg
to assemble TJ strands, no T
ZO-3 Mouse, F9 teratocarcinoma cells Mice viable and fertile, no d
TJ normal except for an incr
Par-3 Mouse Midgestational embryonic le
membrane in epicardial cellsGUK (guanylate kinase) domain (Fig. 1), and thus belong to the
MAGUK (Membrane Associated Guanylate Kinase) family of
proteins [13]. The C-terminal region of ZO-1 and ZO-2 includes
an acidic domain, located just after the GUK domain, and a
proline-rich region containing alternatively spliced regions
(α domain in ZO-1, β domain in ZO-2). The α− isoform of
ZO-1, lacking the α domain, is expressed prior to the α+ isoform
in early mouse development, suggesting that it may be involved
in the initial stages of junction formation [14].
ZO proteins are at the center of a network of protein
interactions. The first PDZ domain of ZO-1, ZO-2 and ZO-3
binds directly to the C-termini of claudins [15] (Fig. 1). Recent
experiments showed that the interaction between the PDZ
domains of ZO-1 and ZO-2 and claudins plays a fundamental
role in the assembly of TJ strands [16]. In fact, mammary
epithelial cells in which ZO-1 expression has been abolished by
targeted deletion, and ZO-2 expression has been reduced by
RNAi-mediated depletion, fail to assemble the TJ strands and
establish a TJ permeability barrier [16] (Table 1). This pheno-
type can be rescued by exogeneous expression of either ZO-1 or
ZO-2, indicating a functional redundancy between these two
proteins in building a scaffold for claudins recruitment. When
ZO-1 mutants that fail to localize to junctions, but target to the
lateral membrane, were expressed in ZO-1 knockout/ZO-2-
depleted cells, ectopic formation of TJ strands was observed
[16]. Taken together, these data demonstrate that an assembly of
a cytoplasmic scaffold of ZO proteins is necessary and suf-
ficient for claudin polymerization into TJ strands. Interestingly,
expression of exogeneous ZO-3 (which is not expressed in this
epithelial cell line) does not rescue the phenotype, and junc-
tional recruitment of ZO-3 requires either ZO-1 or ZO-2, in-
dicating that ZO-3 function is not redundant with ZO-1 and ZO-
2, at least in mammary epithelial cells [16]. It is also noteworthy
that cells lacking ZO-1, ZO-2 and ZO-3 show an apparently
normal apico-basal polarity [16], suggesting that the multimo-
lecular complexes that are involved in the establishment of
apico-basal polarity (PAR-3–PAR-6–aPKC, PALS-1–PATJ-
Crumbs, Dlg-Scribble) (see article by Assemat et al., in this
issue) can still assemble and function normally in the absence of
TJ strands and ZO proteins.References
. Heterozygous mice show hyperplasia, displasia and
lia. Aberrant embryoid bodies, cells unable to differentiate.
[155]
ys p.c. In cells of embryo and embryoid bodies ectoderm,
junctions, loss of polarity, disorganization of AJ and TJ.
[72,73]
g gastrulation. [102]
of several genes, including claudin-2, claudin-6,
mal TJ.
[92]
lly normal, apico-basal polarity normal. Cingulin not
ulation of ZO-2. In combination with ZO-2 knockdown, failure
J barrier, delay in the formation of belt-like adherens junctions.
[16,36]
etected phenotype. Normal differentiation of F9 cells,
eased ZO-2 junctional immunolocalization.
[47]
thality with defective establishment of apical cortical
.
[156]
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and heterodimerization, through interaction with another ZO
protein [17], and for binding to connexins [18,19]. Dimerization
appears crucially important in ZO proteins scaffolding function,
since junctional recruitment of claudins in cells transfected with
a ZO-1 mutant construct occurred only upon chemically-
induced dimerization [16]. The third PDZ domain of ZO-1
interacts in vitro with JAM-1, an Ig-like TJ membrane protein
which is not involved in TJ strands formation, but interacts with
the PDZ domain of PAR-3, providing a link between ZO-1/
claudin-based TJ strands and the PAR-3–PAR-6–aPKC polarity
complex [20]. Surprisingly, the three PDZ domains of ZO-1 are
not sufficient to ensure junctional recruitment [16,21,22],
despite their interaction with different TJ membrane proteins.
An additional region, comprising the SH3, GUK and acidic
domains, is required to recruit ZO-1 to junctions [16,22]. The
GUK region is responsible for occludin interaction [22,23],
suggesting that occludin may be responsible for recruiting ZO-1
to TJ. However, since occludin-deficient cells contain apparent-
ly normal TJ, where ZO-1 is correctly localized [24], alternative
interactions through this region must be involved. One such
interaction could be the one with α-catenin, a cytoplasmic actin-
binding protein that associates with the β-catenin/E-cadherin
complex at adherens junctions, and which interacts with ZO-1
[25,26]. Since constructs lacking the SH3-GUK region of ZO-1
failed to rescue the phenotype of ZO-1 knockout/ZO-2 depleted
cells, it was proposed that this region is involved both in
recruitment of ZO-1 to adherens-type junctions, through α-
catenin interaction, and dimerization [16]. However, ZO-1 can
be recruited to the membrane in cells deficient in α-catenin
[27,28], suggesting that the interaction with α-catenin is not
critical in ZO-1 recruitment to junctions. Other interactions of
ZO-1, for example with the nectin-afadin complex, may be
critical to target ZO-1 to the membrane [29]. In another recent
study, it was shown that ZO-1 depletion causes a delay in
junction assembly, and the isolated SH3 domain of ZO-1 can
rescue this phenotype, although it does not localize correctly to
junctions, suggesting that the SH3 domain may act by titrating
out a yet unidentified factor, which has an inhibitory role inTable 2
Phenotypes of knockdown cells for cytoplasmic TJ proteins
Protein Model Phenotype
ZO-1 MDCK cells Delay in TJ ass
MCF-10A cells and MDCK cells Increased cell d
cysts derived fr
ZO-2 Mammary epithelial cells (EpH4) In conjunction w
no TJ barrier, d
MDCK cells Normal TJ asse
MDCK cells Increased parac
delay in junctio
Cingulin MDCK cells RhoA-dependen
density. Up-reg
MAGI-1 Endothelial cells Suppression of
VE-cadherin-m
Symplekin Intestinal adenocarcinoma
cell line HT29-16E
Loss of immuno
protein levels, d
JEAP/Angiomotin-like-1 Zebrafish embryos Epiboly arrest a
juxtamembranejunction assembly [30] (Table 2). The SH3 domain of ZO-1 is
known to interact in vitro with an unknown kinase [31], the
transcription factor ZONAB [32] and a heat-shock protein [33],
but the role of these proteins in TJ assembly is unclear. In
summary, although it remains to be determined how ZO-1 and
ZO-2 are recruited to nascent junctions, their presence is
necessary and sufficient to assemble claudin-based TJ strands.
The C-terminal, proline-rich domain of ZO-1 interacts with
actin and cortactin [26,34,35], suggesting that ZO-1 functionally
links TJ membrane proteins to the actin cytoskeleton, by binding
to membrane proteins through its N-terminal half, and to actin
through its C-terminal half. The C-terminal region of ZO-1
(lacking the GUK domain, the acidic region and theα domain) is
sufficient for actin interaction, based on colocalization and actin
co-pelleting experiments from cell lysates [34]. However, recent
rescue experiments using ZO-1 knockout/ZO-2 knockdown cell
lines indicate that the acidic domain, located just after the GUK
domain, is required in order for ZO-1 to contribute to the
formation of belt-like adherens junction and linear actin cables in
vivo [36]. In addition, activation of the small GTPase Rac1
appears to be impaired during epithelial polarization in cells
lacking ZO-1 and ZO-2 [36], indicating that ZO-1 and ZO-2may
affect cytoskeletal organization both directly, through interac-
tion with actin, and indirectly, via interaction with other actin-
binding proteins, and with regulators of Rac1 activity.
ZO-2 has a domain organization similar to ZO-1, but con-
tains a shorter C-terminal region, which shows only 25% se-
quence homology to ZO-1 [37,38]. Like ZO-1, ZO-2 binds
claudins through its first PDZ domain, ZO proteins and con-
nexins through the second PDZ domain, actin through its C-
terminal region, and occludin and α-catenin, presumably
through the central region, comprising SH3 and GUK domains
[15,39,40]. These shared protein interactions underline the
concept that ZO-2 and ZO-1 have redundant functions in
promoting claudin assembly into TJ strands [16]. It was recently
shown that silencing of ZO-2 expression leads to changes in the
development and function of the paracellular permeability
barrier of TJ [41] (Table 2). In contrast to these results, however,
no effect of ZO-2 silencing on the barrier properties of culturedReferences
embly. [30]
ensity of MCF-10A cells. Abnormal morphology of
om MDCK cells grown in 3-D matrigel.
[149]
ith KO of ZO-1, failure to assemble TJ strands,
elay in the formation of belt-like adherens junctions.
[16,47]
mbly. [30]
ellular permeability, loss of polarity,
n assembly, atypical monolayer architecture.
[41]
t increase in claudin-2 expression and cell proliferation and
ulation of ZO-3. No effect on organization and assembly of TJ.
[93]
cell–cell contact-induced Rap1 activation and
ediated cell–cell adhesion after Ca++ switch.
[57]
fluorescent staining for ZONAB, decreased ZONAB
ecreased ZONAB activity in reporter assay.
[132]
nd aberrant convergent extension. Disruption of
actin fibers and loss of filopodia and lamellipodia.
[103]
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These discrepancies may be due to different levels of silencing
or target sequences, and should be resolved in the literature in
the coming years.
The domain organization of ZO-3 (130 kDa) is similar to that
of ZO-1 and ZO-2, except that the C-terminal region is the
shortest [42] (Fig. 1). Like ZO-1 and ZO-2, ZO-3 interacts with
claudins, occludin, and actin [40,43]. In addition, an interaction
with the E-cadherin associated protein p120-catenin has been
described [43]. Overexpression of the N-terminal half of ZO-3
(NZO3) delays TJ assembly in cultured cells [44]. It was pro-
posed that excess NZO3 could prevent the intramolecular inter-
action between the COOH-terminal and N-terminal half of
endogeneous ZO-3, and would thus affect interaction with p120
catenin, and RhoA signalling. Interestingly, ZO-3 is the only
one among ZO proteins to be specifically expressed in TJ-
bearing epithelia, whereas ZO-1 and ZO-2 are associated with
cadherin-based junctions in non-epithelial cells and tissues
[45,46]. The targeted deletion of ZO-3 from mouse tissues and
cultured cells does not result in any detectable phenotypic
effects [47] (Table 1). Thus, the physiological function of ZO-3
has not yet been substantially defined, and it may be redundant
with that of other cytoplasmic TJ proteins.
2.2. MAGI proteins
MAGI proteins (MAGUKs with inverted domain structure)
are characterized by two WW domains (instead of the SH3
domain present in ZO proteins), and an inverted arrangement of
protein-interacting domains, with the GUK-WW domains
preceding five PDZ domains (Fig. 1). Among several dif-
ferentially spliced members of the MAGI family, only MAGI-1
and MAGI-3 are associated with TJ [48,49], whereas MAGI-2
is a neural-specific isoform [50].
The PDZ domains of MAGI proteins have been involved in
the interaction with three different classes of proteins (Fig. 1): a)
integral membrane proteins, including different types of re-
ceptors (reviewed in [49]), and two putative TJ-associated Ig-
like adhesion molecules: JAM-4 [51,52], and ESAM [53]; b)
junction-associated signalling molecules, including K-RAS, the
Rho GEF mNEt1, the Rap1 GEF PDZ-GEF1, β-catenin, a
receptor tyrosine phosphatase, and the tumor suppressor PTEN
[49,54–57]; c) the adenoviral oncoprotein E4-ORF1 [58].
Depletion of MAGI-1 from endothelial cells results in the
impairment of VE-cadherin-based cell adhesion, indicating that
MAGI-1 is required for adhesion, via its binding to the Rap1
GEF [57] (Table 2). However, MAGI-1 depletion does not
affect the localization of ZO-1 [57]. Thus, although the specific
role of MAGI proteins in the assembly and function of TJ
remains unclear, the present data suggest that they could have
both scaffolding and signalling functions.
2.3. AF-6/afadin
AF-6/afadin was originally identified as the fusion partner of
the acute lymphoblastic leukemia-1 (ALL-1) protein [59], and
has been immunolocalized both at TJ and at cadherin-basedjunctions [60,61]. AF-6/afadin exists in differentially spliced
variants, distinguishable on the basis of the presence of actin-
binding domains [61]. Afadin contains one PDZ domain, which
interacts with the C-termini of nectin and JAM Ig-like adhesion
molecules, and the Eph subfamily of receptor tyrosine kinases
[62–64]. The first Ras-binding domain within the N-terminus of
afadin regulates the activity of the small GTPase Rap1 and
interacts with Ras [65–67] (Fig. 1). The invertebrate homolog of
afadin, Canoe, is thought to be an effector of Rap1 and both an
effector and target of Ras in vivo [68–70]. ZO-1 also interacts
with the N-terminal region of afadin [60]. The dilute (DIL)
domain of afadin interacts with ADIP (afadin DIL domain-
interacting protein), which in turn binds to α-actinin [71]. In
addition, the C-terminus of l-afadin (the epithelial afadin iso-
form) interacts with ponsin and profilin, thus providing different
molecular interactions through which afadin can link transmem-
brane adhesion proteins to the actin cytoskeleton [61,63,66].
Afadin is crucially important for the establishment of
polarized epithelia during embryogenesis, since targeted
deletion of l-afadin results in early lethality of mouse embryos,
with a loss of apico-basal epithelial polarity, disorganization of
the ectoderm, impaired migration of the mesoderm and loss of
both ectodermal- and mesodermal-derived structures [72,73]
(Table 1). In summary, AF-6 is essential for epithelial morpho-
genesis, through its ability to function as a scaffold, link to the
actin cytoskeleton and modulate the Ras/Rap1 signalling
pathway.
2.4. MUPP1
MUPP1 was originally identified by a yeast 2-hybrid screen,
as a protein interacting with the serotonin receptor [74]. MUPP1
contains a N-terminal MRE domain, and 13 PDZ domains
(Fig. 1) and thus shows a domain organization similar to the
polarity protein PATJ (Le Bivic et al., this issue). In epithelial
cells, MUPP1 is localized at TJ, where it interacts with claudins,
JAM-1, CAR, Crumbs1, through different PDZ domains [75–
78] (Fig. 1). In addition, recent data indicate an interaction of
MUPP1 with the angiomotin/JEAP family of proteins, through
its PDZ2/3 domains [79]. Like other PDZ-containing TJ pro-
teins, MUPP1 is also a target for the adenoviral oncoprotein E4-
ORF1 [80]. The specific role of MUPP1 in TJ assembly and
regulation is not known, although its domain organization and
protein interactions suggest that it has a scaffolding function,
and its function may be redundant with that of PATJ.
3. Non-PDZ proteins of the TJ plaque
3.1. Cingulin and JACOP/paracingulin
Cingulin and JACOP/paracingulin are two vertebrate-
specific, junction-associated proteins characterized by a glob-
ular head domain, a coiled-coil rod domain, and a small
globular tail (Fig. 2).
Cingulin (Mr 140 kDa) was identified as a TJ-specific pro-
tein that co-purified with myosin, and was specifically ex-
pressed in tissues containing epithelial TJ [81,82]. Cingulin
Fig. 2. Schematic representation of cytoplasmic non-PDZ TJ proteins. The major interacting protein partners are indicated. Protein domains are outlined as colored
shapes, or as coiled lines (coiled-coil domains). Numbers on the right indicate amino acid number (in the human protein). ZIM, ZO-1 Interacting Motif; ZF, Zinc
Finger; DH, Dbl homology domain; PH, pleckstrin homology domain; HSF1BD, Hsf1 binding domain; NLS, nuclear localization signals; P-Ser, phosphoserine.
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head domain interacts with several TJ proteins [84–86], andwith
actin [87]. However, the key functional interaction is with ZO-1,Fig. 3. Schematic representation of the different proteins present in the cytoplasmic
CAR, claudins and occludin), which are depicted crossing the membrane bilayers of tw
3, PAR-3, PAR-6, MUPP1, MAGIs and AF-6 (PATJ and PALS-1 have been omitte
(Tiam1, GEF-H1, Tuba, Rap1GEF) are represented by pink stars. Membrane traffic
functional interaction of cytoplasmic TJ proteins with signalling proteins (Cdc42, Rho
RhoA is indirect, through p120 catenin [43]. It is not clear whether the interaction of Z
to proteins that have been shown to have dual nuclear/junctional localization (PAR-through the conserved “ZIM” (ZO-1 Interaction Motif) (Fig. 2),
which is required both for ZO-1 binding, and for junctional
recruitment of cingulin in transfected cells [88]. Indeed, ZO-1region of TJ, some of which interact with TJ membrane proteins (JAM/ESAM/
o adjacent cells. The major PDZ proteins represented here are ZO-1, ZO-2, ZO-
d). Kinases (aPKC, ZAK, c-Yes) are represented by red irregular shapes. GEFs
regulators (Rab3B and Rab13) are represented by circles. The structural and/or
A and Rac1) is indicated by dotted arrows. Note that the interaction of ZO-3 with
O-1 with Rac1 is direct or indirect [16]. Arrows directed to the nucleus are linked
3, PAR-6, ASH1, ZO-1, ZO-2, ZONAB, symplekin, ubinuclein).
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cingulin is recruited to junctions via its interaction with ZO-1
[89]. The coiled-coil rod domain of cingulin is responsible for
dimerization [84], however its heptad repeat pattern indicates
that cingulin does not have the tendency to form filaments or
supramolecular aggregates, like myosins [83]. The rod domain
sequence is particularly well conserved across species [90], and
interacts with the RhoA regulator GEF-H1, resulting in its
inactivation [91].
Cingulin knockout and knockdown epithelial cells contain
normal TJ, based on morphological and functional assays
[92,93] (Tables 1 and 2). In addition, TJ organization and barrier
function is unaffected by inducible up-regulation of full-length
cingulin or its head and rod/tail domains [90]. Thus, cingulin
does not play a direct role in the structure and function of TJ.
However, cingulin mutation or down-regulation alters the ex-
pression of a large number of genes in embryoid bodies, among
which four TJ protein genes (claudin-2, occludin, claudin-6 and
claudin-7) [92]. Cingulin knockdown in MDCK cells up-
regulates claudin-2 and ZO-3 expression, and increases cell
proliferation and monolayer density at confluence [93]. All
these phenotypic effects, except for ZO-3 up-regulation, are
inhibited by expression of dominant-negative RhoA, indicating
that regulation of gene expression and cell proliferation by
cingulin is largely dependent on RhoA [93]. Interestingly,
mammary epithelial cells lacking ZO-1, where cingulin is no
longer associated with junctions, have the same proliferation
rate as parental cells [89], suggesting that either the function of
cingulin in regulating proliferation through RhoA is indepen-
dent of its association with junctions, or that this function is cell-
context-dependent.
JACOP/paracingulin was identified as a novel antigen in a
junction-enriched fraction isolated from mouse liver [94] and as
a protein with sequence and domain organization similar to
cingulin [94,95]. Unlike cingulin, JACOP/paracingulin is
present at both TJ and adherens-type junctions, and is absent
from junctions of the small intestine, whereas it is detected
in endothelial cells [94]. In transfected fibroblasts, JACOP/
paracingulin is recruited to actin stress fibers, and both head and
rod domains are recruited to junctions in transfected epithelial
cells [94]. Whether cingulin and JACOP/paracingulin have
redundant functions, and what proteins JACOP/paracingulin
interacts with, remain to be investigated. However, since
JACOP/paracingulin contains the ZIM domain (Fig. 2), it is
likely that ZO-1 is involved in its junctional recruitment.
3.2. Angiomotin family proteins
Angiomotin (Amot), JEAP (Angiomotin-like-protein1) and
MASCOT (Angiomotin-like-protein2) are three members of a
family of proteins characterized by the presence of a central
coiled-coil domain, and a C-terminal PDZ interaction sequence
motif (Fig. 2). The first member of this family, Amot, was
identified by a yeast two-hybrid screen, as a protein interacting
with and mediating the activity of angiostatin, a circulating
inhibitor of angiogenesis, in endothelial cells [96,97]. JEAP
(Junction Enriched and Associated Protein) was identified as aTJ-associated protein by a fluorescence localization-based
expression cloning method [98]. JEAP was found to be specifi-
cally expressed in epithelial cells of exocrine glands, but not in
other epithelial tissues [98]. MASCOT (MAGI-associated
coiled-coil tight junction protein) was identified as a protein
interacting with the first WW domain of MAGI-1, and showing
sequence similarity to Amot [99] (Fig. 2).
There is some disagreement about the intracellular localiza-
tion of Amot and related proteins. Bratt et al. provided evidence,
based on cross-linking and immunofluorescence experiments,
that Amot is a transmembrane protein, with the angiostatin-
binding domain exposed on the cell surface [100]. On the other
hand, biochemical fractionation experiments suggest that the
Amot family members are peripherally associated to the
membrane [79].
Several protein interactions have been described for Amot
family members. MASCOT and JEAP interact with the first
WW domain of MAGI-1, through a LPXY motif localized in
the N-terminus [99]. In addition, exogeneously expressed Amot
forms a complex with MAGI-1 [100]. The coiled-coil domains
of MASCOT and JEAP mediate self–self interaction, which
could potentially result in the formation of homo- and hetero-
polymers at TJ [99]. On the other hand, the coiled-coil domain
of Amot binds to and recruits to TJ the Cdc42 GAP Rich1,
which is necessary to maintain TJ integrity, by regulating Cdc42
activity [101]. The PDZ domain-binding motif of Amot inter-
acts with PATJ and thus targets Amot to TJ [101]. In addition, it
interacts, as MASCOT, with the PDZ2 and PDZ3 domains of
MUPP1, whereas JEAP only binds to the PDZ3 domain of
MUPP1 [79]. However, the physiological relevance of these
latter interactions remains to be established, since the expres-
sion of dominant-negative mutants of PATJ and MUPP1 does
not affect the localization of Amot family members [79].
Targeted deletion of Amot in mice results in an early
embryonic lethal phenotype, with defects in the migration of
visceral endoderm cells in specific regions of the embryo [102]
(Table 1). In addition, knockdown of angiomotin-like-1 (JEAP)
in zebrafish embryos delays epiboly and impairs convergence
and extension movements, coincident with loss of membrane
protrusions and disorder of F-actin [103] (Table 2). Thus, Amot
and related proteins appear to be of crucial importance in the
regulation of morphogenetic cell movements.
3.3. Signalling proteins and regulators of small GTPases
Different lines of evidence indicate that the cytoplasmic
plaque of TJ contains a large variety of signalling molecules (see
also [6]): 1) kinases such as ZAK [31], WNK4 [104], and c-Yes
[105]; 2) phosphatases, such as PTEN [55] and PP2A [106,107];
3) regulators of membrane traffic, such as Rab13 and the asso-
ciated protein JRAB/MICAL-L2 [108–110], Rab3B [111], and
VAP-33 [112]; and 4) regulators of the activity of small GTPases
(see below). Additional cytoplasmic proteins have been locali-
zed at TJ, for which little is known about functional interactions
with other TJ proteins, and specific roles at TJ: 7H6/barmotin
[113,114], LYRIC [115], 4.1 and spectrin [116]. Finally, the role
of the actomyosin cytoskeleton in regulating TJ structure and
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Recent studies have provided new information about the
functional interaction of guanine nucleotide exchange factors
(GEFs), and GTPase activating proteins (GAPs) with cytoplas-
mic proteins of TJ. GEFs and GAPs act as activators and
inhibitors, respectively, of small GTPases (Rho, Rac, Cdc42),
which in turn control signal transduction pathways linking
membrane receptors to the dynamic assembly and disassembly
of the actin cytoskeleton, cell–cell and cell–substrate adhe-
sions. The molecular organization and function of TJ is severely
affected when the activity of small GTPases is experimentally
altered [117,118], suggesting that GTPase activity must be
finely tuned during each step of junction assembly, from
the initial cell–cell contact, to junction stabilization. Several
adaptor proteins of TJ have been implicated in this regulation,
either by recruiting (and affecting the activity of) GEFs and
GAPs, and/or by restricting their localization, and/or by being
targets of activated GTPases. Initial cell–cell contact and for-
mation of cadherin- and nectin-based primordial adhesions lead
to activation of Rac1 and Cdc42, and inhibition of RhoA ac-
tivity [119]. Active Cdc42 binds to PAR-6, thus activating the
polarity complex, with PAR-3 and atypical protein kinase C
[120,121]. PAR-3 also acts as a scaffold for the Rac1 activator
(GEF) Tiam1 in epithelial and neuronal cells [122–124]. In
MDCK cells, loss of PAR-3 results in increased Rac1 activity
and delayed TJ assembly, suggesting that PAR-3 functions to
inhibit Tiam1 function and/or to restrict its localization at TJ
[122]. The notion that Tiam1 must be present at initial sites of
junction assembly to activate Rac1 is also supported by the
observation that Tiam1-deficient keratinocytes fail to mature
cadherin-based junctions and form TJ [123]. Interestingly,
Tiam1 activity is also important in regulating invasiveness of
lymphoma cells and Ras-transformed epithelial cells [125,126].
The second GEF that interacts with a cytoplasmic TJ protein
is GEF-H1, which interacts with cingulin [91] (Fig. 2). The
inactivation of GEF-H1 following its binding to cingulin in
confluent cultures has been proposed as a mechanism through
which RhoA activity is down-regulated upon junction forma-
tion in confluent cells [91]. Down-regulation of RhoA activity
correlates with inhibition of G1/S phase transition [119].
Indeed, cingulin depletion leads to increased cell proliferation
and claudin-2 expression, in a RhoA-dependent manner [93],
consistent with the idea that cingulin contributes to down-
regulating RhoA activity, and hence cell proliferation, via its
interaction with GEF-H1.
The third GEF which is concentrated at apical junctions is
the Cdc42 GEF Tuba [127]. Although no interaction with TJ
proteins has been identified for this GEF, Tuba depletion im-
pairs both adherens junction and TJ organization, strengthening
the notion that Cdc42 activity is required for TJ formation, and
that multiple GEFs may be sequentially involved in cell junc-
tion assembly, in a redundant or independent manner [127].
The activity of Cdc42 is also regulated by GAPs. The Cdc42
GAP protein Rich1 is targeted to TJ through its interaction with
Amot, which in turn is recruited to TJ by virtue of its interaction
with the polarity complex protein PATJ [101] (Fig. 2). Rich1 isrequired to maintain the integrity and stability of TJ, since TJs
are disassembled more rapidly following calcium depletion in
cells depleted of Rich1 [101]. Overexpression of Amot has the
same effects on TJ as depletion of Rich1, indicating that Amot
inhibits Rich1 GAP activity [101].
In summary, multiple GEFs and GAPs appear to be recruited
into TJ by their interactions with cytoplasmic adaptor proteins,
resulting in a spatially restricted control of small GTPases
activity during the different phases of junction assembly and
stabilization.
3.4. Symplekin
Symplekin is an ubiquitously expressed protein that is en-
riched in the nucleus and associates with TJ in polarized
epithelial cells [128]. Symplekin interacts with the cleavage and
polyadenylation specificity factor CPSF, and is believed to be
involved both in 3′-end processing of pre-mRNA and regulated
RNA polyadenylation in the cytoplasm [129,130]. In addition,
symplekin forms a complex with the heat-shock factor HSF-1
[131], and the transcription factor ZONAB [132]. Reporter
assay experiments indicate that symplekin may regulate the
stability and intracellular levels of ZONAB, with effects on its
transcriptional activity and downstream events, such as expres-
sion of cyclin D1 and cell proliferation [132]. The molecular
mechanisms through which symplekin becomes recruited to TJ,
and its specific role in canonical TJ functions are not known.
4. Regulation of gene expression by TJ plaque proteins
The first indication that TJ plaque proteins may be involved
in the regulation of gene expression was the observation that
transcription factors, and proteins involved in nucleic acid
metabolism and function, as well as several TJ plaque proteins
can have dual localization, both at TJ and in the nucleus. The
nuclear localization was typically detected when cells are ac-
tively proliferating and sub-confluent, whereas the TJ localiza-
tion is detected when cells have reached confluence, suggesting
that TJs act to sequester these factors away from the nucleus
when cells are fully polarized and become confluent [133,134].
ZO-1 was first detected in the nucleus of sub-confluent
cultured cells and of intestinal cells undergoing dissociation of
cell–cell contacts [135]. Living cells expressing a GFP-tagged
form of ZO-1 also exhibited nuclear localization of ZO-1 when
at low confluence [136], consistent with the idea that the nuclear
localization of ZO-1 is inversely related to the extent and/or
maturity of cell–cell contacts [135]. ZO-1 was subsequently
found to interact with ZONAB, e.g. the DNA-binding Y-box
transcription factor DbpA [137], which exhibits dual junctional/
nuclear localization [32]. The TJ localization of other tran-
scription factors, such as ubinuclein [138] and human ASH1
have been reported [139] (see also [2,133]). However, it is still
unclear whether these transcription factors interact with any
specific TJ protein, and how TJ assembly may regulate their
activity. ZO-2 is also detected in the nucleus in sparse cultured
cells, or under conditions of stress [140,141]. Nuclear immu-
nolocalizations, nuclear localization signals, and nuclear export
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PAR-6, PAR-3, and cingulin [133,139,142–146].
There are at least four mechanisms through which TJ proteins
may regulate gene expression and cell proliferation. First, direct
interaction with and sequestration of transcription factors at TJ.
This is what has been shown for ZONAB, whose activity and
nuclear versus junctional localization is dependent on its
interaction with ZO-1 and RalA, once it accumulates at junctions
in confluent epithelial monolayers [32,132,147–149]. Interest-
ingly, high levels of expression of ZONAB/DbpA correlate with
advanced stages of human hepatocellular carcinoma [150].
However, transgenic mice expressing DbpA in hepatocytes do
not develop hepatocellular tumors, despite the up-regulation of
11 genes, and the down-regulation of 9 genes [151]. Thus, it is
unclear whether ZONAB levels/activity actually controls the
proliferative rate of hepatic epithelial cells in vivo. It should also
be noted that although ZO-1 has been implicated as a regulator of
gene expression and cell proliferation, through its interaction
with ZONAB, no increase in cell growth and proliferation was
seen in cells lacking either ZO-1, or ZO-1 and ZO-2 [16,89].
Thus, the ability of ZO-1 and ZONAB to regulate cell prolif-
eration may be context- or cell-type-dependent. The mechanism
of junctional sequestration may also be applied to ZO-2, which
associates and/or colocalizes with several nucleic-acid-binding
proteins: the pre-mRNA splicing protein SC35 [140], the
scaffold attachment factor B (SAF-B) [141] (Fig. 1), the
transcription factors Jun, Fos, AP-1 and CCAAT/enhancer-
binding protein (C/EBP) [152].
The second mechanism through which cytoplasmic TJ
protein may control gene expression and cell proliferation is
by forming a scaffold for (and possibly regulating the activity of)
transcription factors in the nucleus. This type of regulation could
in principle be hypothesized for all TJ plaque proteins that have
been shown to have dual nuclear-junctional localizations,
including ZO-1, ZO-2, and other PDZ proteins [133]. For
example, PAR-6 has recently been shown to be a constitutive
nuclear protein, localized at nuclear “speckles”, where it inter-
acts with Tax, a transcriptional activator of the human T-cell
leukemia virus-1 (HTLV-1) long terminal repeat [144]. Further-
more, PAR-3 interacts with components of the DNA-dependent
protein kinase complex, and may be involved in double-strand
DNA break repair [146].
The third possible mechanism of control of gene expression
by TJ plaque proteins is through the regulation of β-catenin
signalling. Such mechanism could explain the epithelia-
mesenchymal transition induced by the expression of ZO-1
mutants which fail to localize to the membrane, in different types
of cultured cells [21,153,154].
Finally, the fourth mechanism through which TJ plaque
proteins may control gene expression and cell proliferation is by
modulating the activity of small GTPases, which in turn control
the activity of transcription factors. This mechanism has been
shown for cingulin, which controls claudin-2 expression and
cell proliferation in MDCK cells by regulating the activity of
RhoA [93].
In summary, several lines of evidence point to TJ proteins as
multifunctional platforms, that both participate in the architec-ture of TJ, and recruit and regulate signalling molecules and
transcription factors, according to the dynamic changes in the
proliferative and differentiative state of epithelial cells.
5. Conclusions and perspectives
A remarkable progress has been made in recent years in the
identification of cytoplasmic TJ proteins, interacting partner
proteins, and signalling pathways involving these proteins.
Fig. 3 provides a schematic representation of some of the
proteins present at TJ, their interactions withmembrane proteins,
GEFs and GAPs, and their shuttling to and from the nucleus.
The picture that emerges is the one where cytoplasmic
proteins of TJ are dynamic targets and effectors of cellular
processes that coordinate development of apico-basal polarity,
junction assembly, establishment of tissue barriers, and
proliferation. However, the details of this picture remain to be
clarified by additional knockout and knockdown experiments.
One take-home message from studies on mouse models is that
many of the putative roles of TJ proteins, as hypothesized on the
basis of studies on cultured cells, do not always have an equally
significant impact in whole organisms, at least under normal
laboratory conditions. This could be due to functional redun-
dancy between different proteins, but also to context-dependent
differences, and compensatory effects. The phenotypic charac-
terization of knockout mice for TJ proteins will be complicated
by the fact that several of these proteins are also found in other
structures, such as gap junctions. Thus, it will become
increasingly important to use a combination of experimental
approaches in multiple model systems to clarify the physiolog-
ical roles of cytoplasmic TJ proteins.
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